Streetbeat News

Products Services

ETN

TSLA

Eaton plans to integrate Tesla's Powerwall with its new AbleEdge smart breakers by early 2025. This collaboration aims to enhance energy management solutions.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 12:44 pm

SCPX

Scorpius has been selected for a partnership to accelerate the development of medical countermeasures, supporting the Biomedical Advanced Research and Development Authority (BARDA).

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 12:44 pm

ICCT

iCoreConnect Inc. (NASDAQ:ICCT) has expanded its partnership with the Mississippi Dental Association (MDA), which now endorses seven of iCoreConnect's products. This expansion includes products for revenue cycle management and patient experience, building on the initial endorsement of iCoreRx software.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 12:44 pm

RIVN

VWAGY

Volkswagen's $5 billion deal with Rivian has caused frustration among employees at its software division, Cariad, as the CEO was not involved in the discussions. The joint venture aims to develop software for future cars, but has led to uncertainty within Cariad. Volkswagen faces falling demand and potential factory shutdowns, while Rivian plans to use the deal to boost production of its R2 SUV.

Portfolio Pulse from Anan Ashraf

September 09, 2024 | 12:43 pm

IDAI

Trust Stamp (NASDAQ:IDAI) has been granted a new patent for a Personal Identifiable Information Encoder, which aims to enhance data protection and privacy by allowing the utility of PII without storing sensitive data.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 12:42 pm

DDD

3D Systems has achieved a significant milestone in the commercialization of its Oqton Manufacturing OS, which enables on-demand additive manufacturing for regulated markets. Baker Hughes has deployed this system in its Houston facilities, enhancing efficiency and scalability.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 12:41 pm

HOVR

New Horizon Aircraft's shares are rising following the announcement of full-scale development of eVTOL aircraft, accelerated flight tests, and team expansion.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 12:41 pm

TCBP

TC BioPharm is set to begin preclinical studies for its lead therapy, TCB 008, aimed at treating monkeypox. This development could potentially position the company as a key player in addressing the monkeypox outbreak.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 12:40 pm

HOVR

Horizon Aircraft is advancing its development of eVTOL aircraft by accelerating flight tests and expanding its team. This progress could impact companies involved in the eVTOL industry.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 12:40 pm

FEMY

Femasys has received U.S. FDA clearance to market its product, FemChec. This regulatory approval is a significant milestone for the company, potentially impacting its market presence and financial performance.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 12:38 pm